The incidence of Zolpidem use in suspected DUI drivers in Miami-Dade Florida: A comparative study using immunalysis Zolpidem ELISA kit and gas chromatography-mass spectrometry screening

Journal of Analytical Toxicology

Volumn 32, Issue 8, 2008, Pages 688-694

  Reidy, L ^a   Gennaro, W ^a   Steele, B W ^a   Walls, H C ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; SL 84 0589 10; UNCLASSIFIED DRUG; ZALEPLON; ZOLPIDEM; ZOLPIDEM TARTRATE; ZOPICLONE;

ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC KIT; DRIVER; DRUG BLOOD LEVEL; DRUG IDENTIFICATION; DRUG URINE LEVEL; DRUG USE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GAS CHROMATOGRAPHY; HUMAN; INCIDENCE; INSTRUMENT; INTERMETHOD COMPARISON; LIQUID LIQUID EXTRACTION; MALE; MASS SPECTROMETRY; UNITED STATES; URINALYSIS;

EID: 56449102299     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/32.8.688     Document Type: Article

References (22)

1. Data from IMS Health, New York Times, 2006.
2. W.B. Mendalson. Sleepwalking associated with zolpidem. J. Clin. Psychopharmacol. 14: 150 (1994).
3. M.J. Mattila, J. Vanakoski, H. Kalska, and T. Seppala. Effects of alcohol, zolpidem and some other sedatives and hypnotics on human performance and memory. Pharmacol. Biochem. Behav. 59: 917-923 (1998).
4. P. Denis and M.L. Bocca. Effects of zolpidem 10 mg, zopiclone 7.5 mg and flunitrazepam 1 mg on nighttime motor activity. Eur. Neuropsychopharmacol. 13: 111-115 (2003).
5. I. Hindermarch, A. Patat, and N. Stanley. Residual effects of zolpidem following middle of the night administration five hours to one hour before awaking. Human Psychopharmacology Clinical Experimental 16: 159-167 (2001).
6. T.S. Harrison and G.M. Keating. Zolpidem a review of its use in the management of insomnia. CNS Drug Reviews 4: 65-89 (1998).
7. F. Couper and B.K. Logan. Drugs and human performance fact sheet - zolpidem (and zopiclone and zaleplon). NHTSA/DOT report No. DOT HS 809725 (2004).
8. J.C. Verster, E.R. Volkerts, A.H. Schreuder, H.C. Antonia, J.E.E. Eijken, J.H.G. Van Heuckelum, D.S. Veldhuijzen, M.N. Verbaten, I. Paty, M. Darwish, P. Danjou, and A. Patat. Residual effects of middle of the night administration of zaleplon and zolpidem on driving ability, memory functions and psychomotor performance. J. Clin. Psychopharmacol. 22: 576-583 (2002).
9. C.J. Wilkinson. The acute effects of zolpidem, administered alone and with alcohol, on cognitive and psychomotor function. J. Clin. Psychiatry 56: 309-318 (1995).
10. M. Partinen, K. Hiroven, C. Hublin, M. Halavaara, and H. Hiltunen. Effects of after-midnight intake of zolpidem and temazepam on driving ability in women with non-organic insomnia. Sleep Med. 4: 553-561 (2003).
11. D.R. Drover. Comparative pharmacokinetics and pharmacodynamics of short acting hypnosedatives zaleplon, zolpidem and zopiclone. Clin. Pharmacokinet. 43: 227-238 (2004).
12. S. Vajta and J.P. Thenot. Thermospray liquid chromatography tandem mass spectrometry: application to the elucidation of zolpidem metabolism. Biomed. Environ. Mass Spectrom. 15: 223-228 (1983).
13. T. Rohrig and C.M. Moore. Zolpidem Forensic Aspect for the toxicologist and pathologist. Forensic Sci. Med. Pathol. 1: 81-90 (2005).
14. A.A. Piergies, S. Sainati, and B. Roth-Schechter. Lack of cross reactivity of Ambien (zolpidem) with drugs in standard urine drug screen. Arch. Pathol. Lab Med. 4: 392-4 (1997).
15. Zolpidem direct ELISA kit (package insert) Immunalysis Corporation, Pomona, CA, 2004.
16. E.H. Forester, D. Hatchet, and J.C. Garriott. A rapid, comprehensive screening procedure for basic drugs in blood or tissue by gas chromatography. J. Anal. Toxicol. 2: 50-55 (1978).
17. Bulletin of The International Association of Forensic Toxicologist Volume XXXII number 1.
18. D.A. Armbruster, M.D. Tilman, and L.M. Hubbs. Limit of detection and limit of quantification (LOW) comparison of empirical drugs and the statistical method exemplified with GC-MS assay of abused drugs. Clin. Chem. 40: 1233 (1994).
19. M. Partinen, K. Hirvonen, C. Hublin, M. Halavaara, and H. Hiltunen. Effects of after-midnight intake of zolpidem and temazepam on driving ability in women with non-organic insomnia. Sleep Med. 4: 553-561 (2003).
20. M. Villain, M. Cheze, A. Tracqui, B. Ludes, and P. Kinz. Windows of detection of zolpidem in urine and hair; application to two drug facilitated sexual assaults. Forensic Sci. Int. 143: 157-161 (2004).
21. J.H. Lewis and J.H. Vine. A simple and rapid method for the identification of zolpidem carboxylic acid in urine. J. Anal. Toxicol. 31: 195-199 (2007).
22. Ambien CR prescribing information. http://products.sanofiaventis. us/ambien_cr/ambiencr.html#12. March 27, 2008.